At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.

We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create diverse and differentiated medicines to impact millions of patients.